
Sign up to save your podcasts
Or


On the final day of ECTRIMS 2025 in Barcelona, the spotlight turned to MS treatment, including long-awaited clinical trial results. Dr. Sharmilee Gnanapavan, Consultant Neurologist at Barts Health and Princess Alexandra Hospital NHS Trust (UK), joins host Brett Drummond to reflect on key takeaways from the 41st Congress and what the MS community might look forward to at MSToronto 2026.
By The European Committee for Treatment and Research in Multiple Sclerosis4.5
22 ratings
On the final day of ECTRIMS 2025 in Barcelona, the spotlight turned to MS treatment, including long-awaited clinical trial results. Dr. Sharmilee Gnanapavan, Consultant Neurologist at Barts Health and Princess Alexandra Hospital NHS Trust (UK), joins host Brett Drummond to reflect on key takeaways from the 41st Congress and what the MS community might look forward to at MSToronto 2026.

298 Listeners

50 Listeners

28,099 Listeners

111,948 Listeners

151 Listeners

871 Listeners

51 Listeners

5,201 Listeners

6,089 Listeners

127 Listeners

2,040 Listeners

84 Listeners